Cargando…
Ruxolitinib changes the natural course of myelofibrosis and its transplant outcome
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625002/ https://www.ncbi.nlm.nih.gov/pubmed/23589801 http://dx.doi.org/10.5045/br.2013.48.1.68 |
_version_ | 1782266063367438336 |
---|---|
author | Jung, Chul Won |
author_facet | Jung, Chul Won |
author_sort | Jung, Chul Won |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3625002 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis |
record_format | MEDLINE/PubMed |
spelling | pubmed-36250022013-04-15 Ruxolitinib changes the natural course of myelofibrosis and its transplant outcome Jung, Chul Won Blood Res Letter to the Editor Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2013-03 2013-03-25 /pmc/articles/PMC3625002/ /pubmed/23589801 http://dx.doi.org/10.5045/br.2013.48.1.68 Text en © 2013 Korean Society of Hematology http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letter to the Editor Jung, Chul Won Ruxolitinib changes the natural course of myelofibrosis and its transplant outcome |
title | Ruxolitinib changes the natural course of myelofibrosis and its transplant outcome |
title_full | Ruxolitinib changes the natural course of myelofibrosis and its transplant outcome |
title_fullStr | Ruxolitinib changes the natural course of myelofibrosis and its transplant outcome |
title_full_unstemmed | Ruxolitinib changes the natural course of myelofibrosis and its transplant outcome |
title_short | Ruxolitinib changes the natural course of myelofibrosis and its transplant outcome |
title_sort | ruxolitinib changes the natural course of myelofibrosis and its transplant outcome |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625002/ https://www.ncbi.nlm.nih.gov/pubmed/23589801 http://dx.doi.org/10.5045/br.2013.48.1.68 |
work_keys_str_mv | AT jungchulwon ruxolitinibchangesthenaturalcourseofmyelofibrosisanditstransplantoutcome |